— Know what they know.
Not Investment Advice

PVLA NASDAQ

Palvella Therapeutics, Inc.
1W: -4.1% 1M: -13.4% 3M: -5.6% YTD: +32.1% 1Y: +109.5%
$132.47
-0.26 (-0.20%)
 
Weekly Expected Move ±5.3%
$119 $126 $132 $139 $146
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 34 · $1.9B mcap · 10M float · 2.51% daily turnover · Short 47% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NO EDGE
35.2 / 100
NoneWeakNarrowWide
Primary source: Switching Costs  ·  ROIC: 137.5%
Cost Advantage
33
Intangibles
25
Switching Cost
60
Network Effect
22
Scale
27
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. PVLA has No discernible competitive edge (35.2/100). The business operates without significant structural advantages. The primary source of advantage is Switching Costs. ROIC of 137.5% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$207
Low
$226
Avg Target
$240
High
Based on 3 analysts since Aug 4, 2026 earnings
Analyst Recommendations
Strong Buy: 1Buy: 10Hold: 0Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$237.25
Analysts4
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-09-21 Chardan Capital — $210 $240 +30 +59.4% $150.56
2026-08-05 Truist Financial — $210 $207 -3 +34.3% $154.10
2026-08-05 Canaccord Genuity — $204 $232 +28 +52.6% $151.99
2026-07-22 H.C. Wainwright Andrew Fein $255 $270 +15 +87.6% $143.94
2026-05-12 Stephens — Initiated $220 — +80.2% $122.09
2026-02-24 Truist Financial — $190 $210 +20 +74.4% $120.41
2026-02-24 Chardan Capital — $174 $210 +36 +77.1% $118.61
2026-02-24 Stifel Nicolaus — $145 $250 +105 +109.6% $119.25
2026-02-24 H.C. Wainwright — $200 $255 +55 +118.6% $116.66
2026-01-07 Mizuho Securities — Initiated $205 — +126.7% $90.43
2025-12-16 Canaccord Genuity Whitney Ijem $90 $204 +114 +130.7% $88.42
2025-12-16 Raymond James Ryan Deschner $143 $193 +50 +110.9% $91.51
2025-12-15 Chardan Capital — Initiated $174 — +96.8% $88.42
2025-12-15 BTIG Jeff Mukherjee $167 $192 +25 +117.1% $88.42
2025-12-15 Truist Financial — $80 $190 +110 +113.7% $88.89
2025-12-15 UBS Catherine Novack Initiated $143 — +61.7% $88.42
2025-12-15 H.C. Wainwright — $190 $200 +10 +120.7% $90.62
2025-12-15 Cantor Fitzgerald — $200 $210 +10 +136.7% $88.72
2025-12-15 Oppenheimer — $85 $200 +115 +128.8% $87.43
2025-12-11 H.C. Wainwright Andrew Fein $95 $190 +95 +96.8% $96.55
2025-12-05 BTIG — Initiated $167 — +78.0% $93.80
2025-12-04 Craig-Hallum Albert Lowe Initiated $175 — +90.4% $91.91
2025-11-24 Stifel Nicolaus Samimy Annabel $80 $145 +65 +54.1% $94.09
2025-11-19 Raymond James — $54 $143 +89 +47.6% $96.91
2025-11-06 Cantor Fitzgerald — $120 $200 +80 +146.7% $81.08
2025-10-09 Canaccord Genuity — $52 $90 +38 +20.2% $74.85
2025-10-07 Cantor Fitzgerald — $30 $120 +90 +68.1% $71.38
2025-10-02 Truist Financial Danielle Brill Initiated $80 — +29.7% $61.69
2025-09-25 H.C. Wainwright — $75 $95 +20 +64.7% $57.69
2025-09-24 Stifel Nicolaus Annabel Samimy $45 $80 +35 +33.6% $59.87
2025-09-09 Oppenheimer — Initiated $85 — +49.9% $56.71
2025-08-15 H.C. Wainwright Andres Maldonado Initiated $75 — +63.3% $45.94
2025-08-05 Raymond James — Initiated $54 — +43.9% $37.52
2025-05-16 Canaccord Genuity Whitney Ijem Initiated $52 — +135.8% $22.05
2025-03-25 Stifel Nicolaus Annabel Samimy Initiated $45 — +65.0% $27.27
2024-12-18 Cantor Fitzgerald Josh Schimmer Initiated $30 — +154.5% $11.79

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C-
Oct 02, 2026
DCF
3
ROE
1
ROA
1
D/E
2
P/E
1
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. PVLA receives an overall rating of C-. Areas of concern: ROE (1/5), ROA (1/5), D/E (2/5), P/E (1/5), P/B (1/5).
Rating Change History
DateFromTo
2026-10-01 C C-
2026-05-07 C- C
2026-04-01 C C-
2026-03-31 C- C

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ — Grade A+
Profitability
—
Balance Sheet
57
Earnings Quality
39
Growth
—
Value
27
Momentum
—
Safety
100
Cash Flow
—

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
35.39
Safe Zone
Piotroski F-Score
3/9
✗ ✗ ✗ ✓ ✓ ✓ ✗ ✗ ✗
Beneish M-Score
—
—
Ohlson O-Score
-6.74
Bankruptcy prob: 0.1%
Low Risk
Credit Rating
BBB+
Score: 64.7/100
Trend: Improving
Earnings Quality
—
OCF/NI: 0.59x
Accruals: -15.4%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. PVLA scores 35.39, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. PVLA scores 3/9, suggesting weak financial fundamentals — the company fails the majority of these accounting tests. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. PVLA's implied 0.1% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. PVLA receives an estimated rating of BBB+ (score: 64.7/100), with a improving trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-27.43x
PEG
-0.94x
P/S
0.00x
P/B
8.77x
P/FCF
-60.09x
P/OCF
—
EV/EBITDA
-38.88x
EV/Revenue
—
EV/EBIT
-32.30x
EV/FCF
-53.24x
Earnings Yield
-2.81%
FCF Yield
-1.66%
Shareholder Yield
0.00%
Graham Number
—
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. PVLA currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.000
NI / EBT
×
Interest Burden
1.025
EBT / EBIT
×
EBIT Margin
—
EBIT / Rev
×
Asset Turnover
0.000
Rev / Assets
×
Equity Multiplier
1.237
Assets / Equity
=
ROE
-46.6%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. PVLA's ROE of -46.6% is driven by A tax burden ratio of 1.00 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
—
Price/Value
—
Margin of Safety
—
Premium
—

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 454 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$132.47
Median 1Y
$300.67
5th Pctile
$81.07
95th Pctile
$1118.78
Ann. Volatility
80.6%
Analyst Target
$237.25
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Wesley H. Kaupinen
President and Chief Executive Officer
$575,000 $— $3,404,904
Kathleen Goin Operating
rating Officer
$481,300 $— $1,979,837
Matthew E. Korenberg
Chief Financial Officer
$475,300 $— $1,971,437

CEO Pay Ratio

6:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $3,404,904
Avg Employee Cost (SGA/emp): $543,483
Employees: 29

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
29
+107.1% YoY
Revenue / Employee
—
Profit / Employee
$-1,438,448
NI: $-41,715,000
SGA / Employee
$543,483
Avg labor cost proxy
R&D / Employee
$787,621
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE -6.3% -21.8% -45.2% -85.2% -92.1% -34.2% -46.6% -46.63%
ROA -4.5% -15.3% -29.3% -49.2% -56.5% -28.7% -37.7% -37.70%
ROIC 16.4% 48.2% 2.1% 2.8% 1.0% 1.2% 1.4% 1.37%
ROCE -5.7% -16.1% -30.3% -51.7% -74.5% -18.4% -24.9% -24.91%
Gross Margin — — — — — — — —
Operating Margin — — — — — — — —
Net Margin — — — — — — — —
EBITDA Margin — — — — — — — —
FCF Margin — — — — — — — —
OCF Margin — — — — — — — —
ROIC Economic snapshot only -20.98%
Cash ROA snapshot only -14.40%
Valuation
Metric Trend Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio -6.76 -5.13 -11.53 -21.05 -28.23 -33.09 -35.56 -27.427
P/S Ratio — — — — — — — 0.000
P/B Ratio 0.43 1.12 5.21 17.93 42.09 7.02 10.12 8.769
P/FCF -4.95 -5.12 -14.16 -27.23 -47.10 -56.05 -60.09 -60.086
P/OCF — — — — — — — —
EV/EBITDA 13.03 1.18 -9.93 -33.81 -43.56 -37.47 -38.88 -38.877
EV/Revenue — — — — — — — —
EV/EBIT 13.03 1.18 -9.93 -22.06 -31.21 -29.31 -32.30 -32.302
EV/FCF 10.55 1.10 -10.98 -25.36 -44.80 -47.07 -53.24 -53.238
Earnings Yield -14.8% -19.5% -8.7% -4.8% -3.5% -3.0% -2.8% -2.81%
FCF Yield -20.2% -19.5% -7.1% -3.7% -2.1% -1.8% -1.7% -1.66%
Price/Tangible Book snapshot only 10.116
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 7.33 8.84 7.67 6.49 5.20 28.88 21.18 21.179
Quick Ratio 7.33 8.84 7.67 6.49 5.20 28.88 21.18 21.179
Debt/Equity 0.00 0.00 0.30 0.41 0.02 0.00 0.00 0.002
Net Debt/Equity -1.34 -1.36 -1.17 -1.23 -2.05 -1.12 -1.15 -1.153
Debt/Assets 0.00 0.00 0.20 0.24 0.01 0.00 0.00 0.002
Debt/EBITDA -0.00 -0.00 -0.75 -0.84 -0.02 -0.02 -0.01 -0.011
Net Debt/EBITDA 19.15 6.67 2.87 2.49 2.23 7.15 5.00 5.001
Interest Coverage -3.35 -4.50 -5.02 -5.44 -6.17 -7.04 -7.92 -7.922
Equity Multiplier 1.41 1.43 1.54 1.73 2.13 1.14 1.17 1.169
Cash Ratio snapshot only 20.975
Debt Service Coverage snapshot only -6.583
Cash to Debt snapshot only 468.381
FCF to Debt snapshot only -68.249
Defensive Interval snapshot only 1584.0 days
Efficiency & Turnover
Metric Trend Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Inventory Turnover — — — — — — — —
Receivables Turnover 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Payables Turnover 0.00 0.00 0.00 0.00 0.00 0.00 0.00 —
DSO — — — — — — — —
DIO — — — — — — — —
DPO — — — — — — — —
Cash Conversion Cycle — — — — — — — —
Fixed Asset Turnover snapshot only 0.000
Cash Velocity snapshot only 0.000
Growth (YoY)
Metric Trend Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue — — — — — — — —
Net Income — — — — -9.6% -3.1% -1.9% -1.86%
EPS — — — — -1.1% 30.9% -1.2% -1.20%
FCF — — — — -3.6% -1.4% -1.1% -1.08%
EBITDA — — — — -4.9% -2.2% -1.6% -1.57%
Op. Income — — — — -7.8% -2.7% -1.7% -1.69%
OCF Growth snapshot only -1.08%
Asset Growth snapshot only 2.44%
Equity Growth snapshot only 3.54%
Debt Growth snapshot only -96.31%
Shares Change snapshot only 29.89%
Growth Quality
Metric Trend Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability — — — — — — — —
Earnings Stability — — — — — — — —
Margin Stability — — — — — — — —
Rev. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
FCF Positive Streak 0 0 0 0 0 0 0 0
Earnings Persistence — — — — — — — —
Earnings Smoothness — — — — — — — —
ROE Trend — — — — — — — —
Gross Margin Trend — — — — — — — —
FCF Margin Trend — — — — — — — —
Sustainable Growth Rate — — — — — — — —
Internal Growth Rate — — — — — — — —
Cash Flow Quality
Metric Trend Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income 1.36 1.00 0.81 0.77 0.60 0.59 0.59 0.592
FCF/OCF 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
FCF/Net Income snapshot only 0.592
CapEx/Revenue — — — — — — — —
CapEx/Depreciation snapshot only 0.000
Accruals Ratio 0.02 0.00 -0.05 -0.11 -0.23 -0.12 -0.15 -0.154
Sloan Accruals snapshot only 1.019
Dividends & Buybacks
Metric Trend Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio — — — — — — — —
FCF Payout Ratio — — — — — — — —
Total Payout Ratio — — — — — — — —
Div. Increase Streak — — — — — — — —
Chowder Number — — — — — — — —
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield 0.0% -0.1% -0.2% -0.1% -0.1% -14.2% -10.6% -10.60%
Total Shareholder Return 0.0% -0.1% -0.2% -0.1% -0.1% -14.2% -10.6% -10.60%
DuPont Factors
Metric Trend Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Interest Burden (EBT/EBIT) 0.90 1.07 1.11 1.13 1.16 1.05 1.03 1.025
EBIT Margin — — — — — — — —
Asset Turnover 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Equity Multiplier 1.41 1.43 1.54 1.73 1.63 1.19 1.24 1.237
Per Share
Metric Trend Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $-1.77 $-5.45 $-1.95 $-2.98 $-3.71 $-3.77 $-4.30 $-4.30
Book Value/Share $28.13 $24.97 $4.32 $3.50 $2.49 $17.75 $15.11 $15.11
Tangible Book/Share $28.13 $24.97 $4.32 $3.50 $2.49 $17.75 $15.11 $15.11
Revenue/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
FCF/Share $-2.42 $-5.46 $-1.59 $-2.30 $-2.22 $-2.22 $-2.54 $-2.54
OCF/Share $-2.42 $-5.46 $-1.59 $-2.30 $-2.22 $-2.22 $-2.54 $-2.54
Cash/Share $37.56 $33.97 $6.37 $5.75 $5.15 $20.01 $17.45 $17.45
EBITDA/Share $-1.96 $-5.09 $-1.76 $-1.73 $-2.29 $-2.79 $-3.48 $-3.48
Debt/Share $0.00 $0.00 $1.31 $1.45 $0.06 $0.04 $0.04 $0.04
Net Debt/Share $-37.56 $-33.97 $-5.06 $-4.30 $-5.10 $-19.97 $-17.42 $-17.42
Academic Models
Metric Trend Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — — — — 35.386
Altman Z-Prime snapshot only 65.389
Piotroski F-Score 1 1 2 2 1 2 3 3
Beneish M-Score — — — — — — — —
Ohlson O-Score snapshot only -6.743
ROIC (Greenblatt) snapshot only -24.91%
Net-Net WC snapshot only $15.08
Credit
Metric Trend Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only BBB+
Credit Score 42.18 42.24 60.64 63.45 64.94 64.92 64.66 64.662
Credit Grade snapshot only 8
Credit Trend snapshot only 4.022
Implied Spread (bps) snapshot only 225.000
Industry Credit Rank snapshot only 62
Sector Credit Rank snapshot only 58

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms